Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/E ratio is N/A as of 2026-10-06T18:27:14.188Z.
Calculation as of: 2026-10-06T18:27:14.188Z.
Quote observation: 2026-10-06T18:25:12.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 4147f1633fe526555426f89ecb5945f37dfc8ef4561f7e6db8f1148c00751c21
PE RATIO
N/A
Market Cap
$5.85B
PE Ratio
78.37
TTM Avg
136.52
3Y Avg
215.24
5Y Avg
141.48
Market Cap
$5.96B
PE Ratio
31.80
TTM Avg
54.86
3Y Avg
51.97
5Y Avg
46.21
| NAME | MARKET CAP | PE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | $5.92B | N/A | N/A | N/A | N/A |
| Iovance Biotherapeutics, Inc. (IOVA)vs › | $5.90B | N/A | N/A | N/A | N/A |
| Kiniksa Pharmaceuticals International, plc (KNSA)vs › | $5.85B | 78.37 | 136.52 | 215.24 | 141.48 |
| Ligand Pharmaceuticals Incorporated (LGND)vs › | $5.96B | 31.80 | 54.86 | 51.97 | 46.21 |
| GRAIL Inc. (GRAL)vs › | $5.97B | N/A | N/A | N/A | N/A |
| CG Oncology Inc. (CGON)vs › | $5.65B | N/A | N/A | N/A | N/A |
| Rhythm Pharmaceuticals, Inc. (RYTM)vs › | $6.22B | N/A | N/A | N/A | N/A |
| RadNet, Inc. (RDNT)vs › | $5.53B | N/A | 670.99 | 322.02 | 261.00 |
| MiniMed Group, Inc. Common Stock (MMED)vs › | $5.49B | N/A | N/A | N/A | N/A |
| PTC Therapeutics, Inc. (PTCT)vs › | $5.32B | N/A | 8.39 | 8.39 | 8.39 |
Trailing P/E
N/A
Forward P/E
N/A
Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.
Calculation:
Current Price
$94.55
Forward EPS (Est.)
$-4.08
Forward P/E
N/A
Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
